tiprankstipranks
Trending News
More News >
Alzamend Neuro announces initiation date of Phase II trial of AL001
PremiumThe FlyAlzamend Neuro announces initiation date of Phase II trial of AL001
2M ago
Alzamend Neuro files to sell 75.775M shares of common stock for holders
Premium
The Fly
Alzamend Neuro files to sell 75.775M shares of common stock for holders
2M ago
Alzamend Neuro announces initiation of Phase II trial of AL001
Premium
The Fly
Alzamend Neuro announces initiation of Phase II trial of AL001
2M ago
Alzamend Neuro announces full data set from nonclinical AL001 study
PremiumThe FlyAlzamend Neuro announces full data set from nonclinical AL001 study
6M ago
Alzamend Neuro receives final full data set from AL001 trial
Premium
The Fly
Alzamend Neuro receives final full data set from AL001 trial
7M ago
Alzamend Neuro Regains Nasdaq Compliance After Strategic Appeal
Premium
Company Announcements
Alzamend Neuro Regains Nasdaq Compliance After Strategic Appeal
7M ago
Alzamend Neuro partners with Massachusetts General Hospital
PremiumThe FlyAlzamend Neuro partners with Massachusetts General Hospital
9M ago
Alzamend Neuro and Mass General team for trial of AL001 for Alzheimer’s
Premium
The Fly
Alzamend Neuro and Mass General team for trial of AL001 for Alzheimer’s
9M ago
Alzamend Neuro Meets Nasdaq Standards, Embraces Social Media
Premium
Company Announcements
Alzamend Neuro Meets Nasdaq Standards, Embraces Social Media
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100